BIOPYRANIA aims to develop innovative and sustainable solutions for the polymer sector, with the ambition of reducing environmental impact and facilitating the transition towards a circular economy. The project aims to produce new classes of polyamides (PA) and polybenzimidazole (PBI) from biobased pyrazine, synthesized from acids obtained from second-generation (2G) woody biomass.
Only safe, non-corrosive solvents will be used in this process, ensuring sustainability even during production. The ultimate goal is to provide high-performance, environmentally friendly alternatives to fossil fuel products, responding to growing industry demands and European sustainability regulations such as the Sustainable Product Initiative (SPI). New polymers, for strategic sectors such as electric mobility and clean hydrogen, will help reduce dependence on fossil resources, promoting a more sustainable and technologically advanced future.
BioG3D is responsible for the evaluation of the safety and potential health impacts of materials developed within the project, ensuring they meet regulatory and health standards. This role involves the in vitro toxicity assessment of the monomers and the polymers that will be developed within BIOPYRANIA, using specific cell lines relevant to the application. Cytotoxicity, oxidative stress, and genotoxicity will be measured to assess the biological effects of these materials. Additionally, microscopy will be used to evaluate morphological changes, providing critical insights into risks associated with respiratory and dermal exposure.
